009420

Hanall Biopharma Co., Ltd.

KR Healthcare Drug Manufacturers - Specialty & Generic

Latest week
10 Jul 2026
Close
57400.000000
Fair value
37459.294872
Next-week expectancy
Positive 55.01%
Sharemaestro

009420 Chart Pack

Hanall Biopharma Co., Ltd.

Exchange
KSC
Latest week
10 Jul 2026
Close
57400.000000
Fair value
37459.294872
Next-week expectancy
Positive 55.01%
Generated
17 Jul 2026 11:10
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, 009420 rose 11.24%, moving from 51,600.00 to 57,400.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 10 of the last 12 weeks. Relative Strength is -16.24 and has improved across the 12-week window. Market Dynamics is 0.21 on the latest week. Next-week expectancy is positive at 55.01% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
57,400.00
12-Week Change
11.24%
Trend Signal
Active
Next-Week Expectancy
Positive 55.01%
Signal Weeks
10 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-16.24
Market Dynamics
0.21

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
57,400.00
12-Week Change
11.24%
Trend Signal
Active
Next-Week Expectancy
Positive 55.01%
Signal Weeks
10 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
-16.24
Market Dynamics
0.21

Over the latest 12 completed weeks ending 2026-07-10, 009420 rose 11.24%, moving from 51,600.00 to 57,400.00. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 10 of the last 12 weeks. Relative Strength is -16.24 and has improved across the 12-week window. Market Dynamics is 0.21 on the latest week. Next-week expectancy is positive at 55.01% based on similar historical setup states.

Industry Peers

South Korea equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
002390 HANDOK Inc. KSC 10 Jul 2026 7410.00 8080.00 7410.00 7890.00 6.48%
170900 Dong-A ST Co., Ltd. KSC 10 Jul 2026 35250.00 36650.00 34250.00 36350.00 3.12%
016580 Whan In Pharm Co.,Ltd. KSC 10 Jul 2026 9700.00 10050.00 9460.00 10000.00 3.09%
008490 Suheung Co., Ltd. KSC 10 Jul 2026 19220.00 21250.00 19190.00 19800.00 3.02%
007570 Ilyang Pharmaceutical Co.,Ltd KSC 10 Jul 2026 8330.00 8690.00 7920.00 8570.00 2.88%
002720 Kukje Pharma Co., Ltd. KSC 10 Jul 2026 3380.00 3500.00 3270.00 3455.00 2.22%
033270 Korea United Pharm Inc. KSC 10 Jul 2026 17360.00 17890.00 16900.00 17730.00 2.13%
000020 Dongwha Pharm.Co.,Ltd KSC 10 Jul 2026 5070.00 5410.00 4950.00 5160.00 1.78%
271980 Jeil Pharmaceutical Co.,Ltd KSC 10 Jul 2026 10130.00 10280.00 9590.00 10230.00 0.99%
185750 Chong Kun Dang Pharmaceutical Corp. KSC 10 Jul 2026 69700.00 71900.00 67300.00 70200.00 0.72%
000640 Dong-A Socio Holdings Co., Ltd. KSC 10 Jul 2026 82500.00 86900.00 80800.00 82900.00 0.48%
096760 JW Holdings Corporation KSC 10 Jul 2026 3895.00 3905.00 3620.00 3905.00 0.26%
003850 Boryung Corporation KSC 10 Jul 2026 8450.00 8580.00 8020.00 8470.00 0.24%
002620 Jeil Pharma Holdings Inc KSC 10 Jul 2026 6670.00 6720.00 6210.00 6680.00 0.15%
001067 JW Pharmaceutical Corporation KSC 10 Jul 2026 43200.00 43200.00 42000.00 43200.00 0.00%
069620 Daewoong Pharmaceutical Co., Ltd KSC 10 Jul 2026 132500.00 139800.00 130000.00 131900.00 -0.45%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.